Children's Cancer Research Institute, Vienna, Austria.
Leukemia. 2010 Apr;24(4):706-14. doi: 10.1038/leu.2010.4. Epub 2010 Feb 11.
Invasive adenovirus (AdV) infections are associated with high morbidity and mortality in allogeneic stem cell transplant recipients. We observed that molecular detection of the virus in stool specimens commonly precedes AdV viremia, suggesting that intestinal infections may represent a common source of virus dissemination. To address this notion, we have investigated 153 consecutive allogeneic transplantations in 138 pediatric patients by quantitative monitoring of AdV in stool specimens and peripheral blood by a pan-adenovirus real-time (RQ)-PCR approach. AdV was detectable in serial stool specimens in all cases of AdV viremia during the post-transplant course (P<0.0001). The incidence of AdV viremia in individuals with peak virus levels in stool specimens above 1 x 10E6 copies per gram (n=22) was 73% vs 0% in patients with AdV levels in stool specimens below this threshold (n=29; P<0.0001). Serial measurement of AdV levels in stool specimens by RQ-PCR permitted early diagnosis of impending invasive infection with a sensitivity and specificity of 100% (95% confidence interval (CI) 96-100%) and 83% (95% CI 67-92%), respectively. The median time span between detection of AdV loads in stool specimens above 1 x 10E6 copies per gram and first observation of viremia was 11 days (range 0-192). Quantitative monitoring of the AdV load in stool specimens therefore provides a rationale for early initiation of antiviral treatment with the aim of preventing progression to life-threatening invasive infection.
侵袭性腺病毒(AdV)感染与异基因造血干细胞移植受者的高发病率和死亡率有关。我们观察到,病毒在粪便标本中的分子检测通常先于 AdV 病毒血症,这表明肠道感染可能代表病毒传播的常见来源。为了验证这一观点,我们通过实时(RQ)-PCR 方法对 138 例儿科患者的 153 例连续异基因移植进行了研究,对粪便和外周血样本中的 AdV 进行定量监测。在移植后过程中,所有 AdV 病毒血症病例的粪便标本中均可检测到 AdV(P<0.0001)。在粪便标本中病毒水平峰值超过 1×10E6 拷贝/克(n=22)的个体中,AdV 病毒血症的发生率为 73%,而在 AdV 水平低于此阈值的患者中(n=29)为 0%(P<0.0001)。通过 RQ-PCR 对粪便标本中 AdV 水平的连续测量可以早期诊断即将发生的侵袭性感染,其敏感性和特异性分别为 100%(95%置信区间(CI)96-100%)和 83%(95%CI 67-92%)。在粪便标本中检测到 AdV 负荷超过 1×10E6 拷贝/克与首次观察到病毒血症之间的中位时间跨度为 11 天(范围 0-192)。因此,对粪便标本中 AdV 载量的定量监测为早期启动抗病毒治疗提供了依据,目的是预防进展为危及生命的侵袭性感染。